Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Stirling Products has started manufacturing operations at its pharmaceutical plant in Cape Breton, Nova Scotia, Canada, following license from Health Canada.
Subscribe to our email newsletter
Initially, Stirling Products will manufacture 300kgs of tableted products and will gradually increase its production with the signing of more contracts which are now in process.
Stirling Products’ 4,270 square metre pharmaceutical facility is engaged in manufacturing and commercializing prescription, over-the counter, netraceutical, and natural health products.
With current fit-out and configuration the plant has an annual capacity to manufacture and package over 550 million tablets, 5 million bottles and blend up to 1.5 million kg of product.